COST ANALYSIS OF SCREENING ACCORDING TO ECCO GUIDELINES FOR PREVENTION OF OPPORTUNISTIC INFECTIONS IN INFLIXIMAB-TREATED IBD PATIENTS

被引：1

作者：

Metz, A. ^{[1
]}

Elliott, T. ^{[2
]}

Hull, B. ^{[2
]}

Duncan, J. ^{[2
]}

Sastrillo, M. ^{[2
]}

Smith, M. ^{[2
]}

Sanderson, J. D. ^{[2
]}

Irving, P. M. ^{[2
]}

机构：

[1] Addenbrookes Hosp, Cambridge, England

[2] Guys & St Thomas Hosp, London SE1 9RT, England

来源：

GUT | 2011年 / 60卷

关键词：

D O I：

10.1136/gut.2011.239301.301

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：A142 / A142

页数：1

共 50 条

[41] Screening for asymptomatic cardiovascular disease with noninvasive imaging in patients at high-risk and low-risk according to the European Guidelines on Cardiovascular Disease Prevention: The SMART study
Goessens, BMB
Visseren, FLJ
Algra, A
Banga, JD
van der Graaf, Y
JOURNAL OF VASCULAR SURGERY, 2006, 43 (03) : 525 - 532
[42] Pediatric IBD Patients Treated With Infliximab and Proactive Drug Monitoring Benefit From Early Concomitant Immunomodulatory Therapy: A Retrospective Analysis of a 10-Year Real-Life Cohort
Hoelz, Hannes
Bragagna, Lena
Litwin, Anna
Koletzko, Sibylle
Thi, Thu Giang Le
Schwerd, Tobias
INFLAMMATORY BOWEL DISEASES, 2023, 30 (11) : 2004 - 2018
[43] COST-UTILITY ANALYSIS OF POSACONAZOLE VERSUS FLUCONAZOLE FOR PREVENTION OF INVASIVE FUNGAL INFECTIONS IN PATIENTS WITH GRAFT-VERSUS- HOST DISEASE IN SWEDEN
Lundberg, J. G.
Jensen, A., V
Bjorkholm, M.
Hoglund, M.
Akerborg, O.
VALUE IN HEALTH, 2013, 16 (07) : A359 - A359
[44] Posaconazole versus fluconazole or itraconazole for prevention of invasive fungal infections in patients undergoing intensive cytotoxic therapy for acute myeloid leukemia or myelodysplasia: a cost effectiveness analysis
Dranitsaris, George
Khoury, Haytham
SUPPORTIVE CARE IN CANCER, 2011, 19 (11) : 1807 - 1813
[45] Posaconazole versus fluconazole or itraconazole for prevention of invasive fungal infections in patients undergoing intensive cytotoxic therapy for acute myeloid leukemia or myelodysplasia: a cost effectiveness analysis
George Dranitsaris
Haytham Khoury
Supportive Care in Cancer, 2011, 19 : 1807 - 1813
[46] Comparison of clinical outcomes by induction therapy response status in patients with Inflammatory Bowel Disease (IBD) treated with subcutaneous (SC) versus intravenous (IV) infliximab (IFX): Post hoc analysis of a pivotal, randomised controlled trial
Vuitton, L.
Mathieu, N.
Ye, B. D.
Kim, D. H.
Jeong, A. L.
Lee, Y. N.
Schreiber, S.
JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1733 - I1734
[47] Cost-Effectiveness Analysis of Non-Statin Lipid-Modifying Agents for Secondary Cardiovascular Disease Prevention Among Statin-Treated Patients in Thailand
Kongpakwattana, Khachen
Ademi, Zanfina
Chaiyasothi, Thanaputt
Nathisuwan, Surakit
Zomer, Ella
Liew, Danny
Chaiyakunapruk, Nathorn
PHARMACOECONOMICS, 2019, 37 (10) : 1277 - 1286
[48] Cost-Effectiveness Analysis of Non-Statin Lipid-Modifying Agents for Secondary Cardiovascular Disease Prevention Among Statin-Treated Patients in Thailand
Khachen Kongpakwattana
Zanfina Ademi
Thanaputt Chaiyasothi
Surakit Nathisuwan
Ella Zomer
Danny Liew
Nathorn Chaiyakunapruk
PharmacoEconomics, 2019, 37 : 1277 - 1286
[49] Cost Effectiveness Analysis and Payment Policy Recommendation Population Based Survey With Big Data Methodology of Readmission Prevention of Patients With Paroxysmal Supraventricular Tachycardia Treated by Radiofrequency Catheter Ablation
Li, Ai Hsien A.
Chan, Chien-Lung
Chung, Hsiang-An
CIRCULATION, 2018, 138
[50] Cost Effectiveness Analysis and Payment Policy Recommendation-Population-Based Survey with Big Data Methodology for Readmission Prevention of Patients with Paroxysmal Supraventricular Tachycardia treated with Radiofrequency Catheter Ablation
Chan, Chien-Lung
Li, Ai-Hsien Adams
Chung, Hsiang-An
Dinh-Van Phan
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2020, 17 (07)

← 1 2 3 4 5 →